Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms-Reference-Cited by-同舟云学术

Influence of corticosteroid therapy on viral reactivation in drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

Published:2020-03-11 Issue:5 Volume:47 Page:476-482
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Tohyama Mikiko¹²^ORCID,Hashimoto Koji²,Oda Fumiko²,Namba Chika²^ORCID,Sayama Koji²

Affiliation:

1. Department of Dermatology National Hospital Organization Shikoku Cancer Center Matsuyama791-0280 Japan

2. Department of Dermatology Ehime University Graduate School of Medicine Toon791-0295 Japan

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15294

Reference24 articles.

1. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations

2. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

3. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome

4. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome

5. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and Myocarditis: A Case Report and Literature Review on Fatal Complications of Reactivated Viral Infections;Iranian Journal of Allergy, Asthma and Immunology;2024-06-05

2. Herpesvirus activated NF-κB-mediated antigen processing and presentation to aggravate trichloroethylene-induced hypersensitivity dermatitis;Toxicology Letters;2024-03

3. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes;The Journal of Allergy and Clinical Immunology: In Practice;2023-10

4. A diagnostic challenge: Life-threatening drug reaction with eosinophilia and systemic symptoms in the setting of a SARS-CoV-2 and human herpesvirus-6 reactivation in a patient with severe hepatic injury on bupropion;JAAD Case Reports;2023-09

5. A case of drug‐induced hypersensitivity syndrome complicated with fulminant type 1 diabetes and type 2 myocardial infarction;The Journal of Dermatology;2023-08-10